Average Co-Inventor Count = 5.08
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (24 from 2,405 patents)
2. Kinnate Biopharma Inc. (8 from 14 patents)
32 patents:
1. 12246008 - 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels
2. 12247031 - Cyclobutyl pyrazolopyrimidine PDE9 inhibitors
3. 12195445 - 2-amino-N-heteroaryl-nicotinamides as Na1.8 inhibitors
4. 12122800 - Inhibitors of MEK kinase
5. 11814384 - Inhibtors of Raf kinases
6. 11802122 - 2-oxoimidazolidine-4-carboxamides as NA1.8 inhibitors
7. 11780862 - Inhibitors of MEK kinase
8. 11753395 - Inhibitors of MET kinase
9. 11746095 - Inhibtors of RAF kinases
10. 11407737 - Inhibitors of RAF kinases
11. 11377438 - 2-amino-n-heteroaryl-nicotinamides as Na1.8 inhibitors
12. 11377431 - Inhibitors of RAF kinases
13. 11345681 - Inhibitors of fibroblast growth factor receptor kinases
14. 11161819 - Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists
15. 11028092 - Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors